34.68
price down icon3.32%   -1.19
after-market Dopo l'orario di chiusura: 34.68
loading
Precedente Chiudi:
$35.87
Aprire:
$35.93
Volume 24 ore:
1.08M
Relative Volume:
0.62
Capitalizzazione di mercato:
$4.47B
Reddito:
-
Utile/perdita netta:
$-507.65M
Rapporto P/E:
-7.5391
EPS:
-4.6
Flusso di cassa netto:
$-616.24M
1 W Prestazione:
-2.91%
1M Prestazione:
+6.45%
6M Prestazione:
-60.89%
1 anno Prestazione:
-58.16%
Intervallo 1D:
Value
$34.66
$35.93
Intervallo di 1 settimana:
Value
$34.66
$37.00
Portata 52W:
Value
$27.66
$121.06

Vaxcyte Inc Stock (PCVX) Company Profile

Name
Nome
Vaxcyte Inc
Name
Telefono
650-837-0111
Name
Indirizzo
825 INDUSTRIAL ROAD, STE. 300, SAN CARLOS, CA
Name
Dipendente
414
Name
Cinguettio
Name
Prossima data di guadagno
2024-11-04
Name
Ultimi documenti SEC
Name
PCVX's Discussions on Twitter

Confronta PCVX con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
PCVX
Vaxcyte Inc
34.68 4.73B 0 -507.65M -616.24M -4.60
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
468.41 120.60B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
558.14 60.80B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
330.55 42.87B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
598.79 36.23B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
305.74 31.54B 3.81B -644.79M -669.77M -6.24

Vaxcyte Inc Stock (PCVX) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2025-04-22 Iniziato Cantor Fitzgerald Overweight
2024-12-20 Iniziato Goldman Buy
2023-12-07 Iniziato Mizuho Buy
2023-04-18 Iniziato TD Cowen Outperform
2023-01-03 Reiterato Needham Buy
2022-12-15 Iniziato Guggenheim Buy
2022-11-17 Iniziato BTIG Research Buy
2021-12-29 Ripresa Jefferies Buy
2021-06-24 Ripresa Jefferies Buy
2020-07-07 Iniziato BofA Securities Buy
2020-07-07 Iniziato Cantor Fitzgerald Overweight
2020-07-07 Iniziato Needham Buy
Mostra tutto

Vaxcyte Inc Borsa (PCVX) Ultime notizie

pulisher
Jul 28, 2025

Should I hold or sell Vaxcyte Inc. stock in 2025Best Dividend Insights For Fast Growth - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 28, 2025

What institutional investors are buying Vaxcyte Inc. stockChart Pattern Ideas For Fast Growth - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 28, 2025

What is the risk reward ratio of investing in Vaxcyte Inc. stockInvest smarter with daily stock recommendations - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 28, 2025

What are analysts’ price targets for Vaxcyte Inc. in the next 12 monthsSmart Portfolio Ideas For Fast Growth - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 28, 2025

Is Vaxcyte Inc. stock overvalued or undervaluedBuild wealth steadily with smart trading - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 27, 2025

How strong is Vaxcyte Inc. company’s balance sheetPhenomenal investment performance - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

Is Vaxcyte Inc. a growth stock or a value stockRemarkably fast returns - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

What catalysts could drive Vaxcyte Inc. stock higher in 2025Rapid growth trajectories - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

When is Vaxcyte Inc. stock expected to show significant growthGet insider insights into market trends - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

Is it the right time to buy Vaxcyte Inc. stockCapitalize on fast-moving trading opportunities - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 25, 2025

What analysts say about Vaxcyte Inc. stockExceptional ROI - PrintWeekIndia

Jul 25, 2025
pulisher
Jul 24, 2025

What drives Vaxcyte Inc. stock priceHigh-yield trading alerts - Autocar Professional

Jul 24, 2025
pulisher
Jul 23, 2025

Vaxcyte Inc. Stock Analysis and ForecastRapid market gains - jammulinksnews.com

Jul 23, 2025
pulisher
Jul 23, 2025

Is Vaxcyte Inc. a good long term investmentFree Trading Strategy Suggestions - Autocar Professional

Jul 23, 2025
pulisher
Jul 19, 2025

Mizuho Maintains an Overweight Rating on Vaxcyte (PCVX) - MSN

Jul 19, 2025
pulisher
Jul 19, 2025

Nisa Investment Advisors LLC Buys 293 Shares of Vaxcyte, Inc. (NASDAQ:PCVX) - Defense World

Jul 19, 2025
pulisher
Jul 17, 2025

How the (PCVX) price action is used to our Advantage - news.stocktradersdaily.com

Jul 17, 2025
pulisher
Jul 16, 2025

Vaxcyte’s High-Stakes Bet On Next-Gen Pneumonia Vaccines - Finimize

Jul 16, 2025

Vaxcyte Inc Azioni (PCVX) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading

Vaxcyte Inc Azioni (PCVX) insider trading

Commercio interno Relazione Data Transazione Costo #Azioni Valore ($) #Azioni Totale
GUGGENHIME ANDREW
PRESIDENT AND CFO
Apr 07 '25
Option Exercise
20.93
4,777
99,983
131,950
PICKERING GRANT
CHIEF EXECUTIVE OFFICER
Apr 04 '25
Option Exercise
8.96
20,533
183,888
518,775
Eydelman Mikhail
SVP, GEN COUNSEL & CORP SEC
Mar 05 '25
Option Exercise
21.41
5,000
107,050
46,620
Eydelman Mikhail
SVP, GEN COUNSEL & CORP SEC
Mar 05 '25
Sale
70.74
5,000
353,699
41,620
$77.38
price up icon 10.28%
$37.27
price up icon 0.57%
$105.00
price up icon 3.19%
$26.74
price down icon 2.59%
$111.48
price down icon 1.16%
biotechnology ONC
$305.74
price up icon 3.81%
Capitalizzazione:     |  Volume (24 ore):